🎉 M&A multiples are live!
Check it out!

Dimerix Valuation Multiples

Discover revenue and EBITDA valuation multiples for Dimerix and similar public comparables like Vivoryon Therapeutics, Pharming, and Galapagos.

Dimerix Overview

About Dimerix

Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.


Founded

1975

HQ

Australia
Employees

12

Website

dimerix.com

Financials

LTM Revenue $3.7M

LTM EBITDA -$12.0M

EV

$149M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Dimerix Financials

Dimerix has a last 12-month revenue of $3.7M and a last 12-month EBITDA of -$12.0M.

In the most recent fiscal year, Dimerix achieved revenue of n/a and an EBITDA of -$16.2M.

Dimerix expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Dimerix valuation multiples based on analyst estimates

Dimerix P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue n/a n/a XXX XXX XXX
Gross Profit n/a n/a XXX XXX XXX
Gross Margin NaN% NaN% XXX XXX XXX
EBITDA -$14.4M -$16.2M XXX XXX XXX
EBITDA Margin NaN% NaN% XXX XXX XXX
Net Profit -$6.6M -$8.7M XXX XXX XXX
Net Margin NaN% NaN% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Dimerix Stock Performance

As of March 17, 2025, Dimerix's stock price is AUD 0 (or $0).

Dimerix has current market cap of AUD 257M (or $163M), and EV of AUD 236M (or $149M).

See Dimerix trading valuation data

Dimerix Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$149M $163M XXX XXX XXX XXX $-0.02

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Dimerix Valuation Multiples

As of March 17, 2025, Dimerix has market cap of $163M and EV of $149M.

Dimerix's trades at 40.1x LTM EV/Revenue multiple, and -12.5x LTM EBITDA.

Analysts estimate Dimerix's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Dimerix and 10K+ public comps

Dimerix Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $149M XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA -10.4x XXX XXX XXX
P/E -14.0x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 605.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Dimerix Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Dimerix Valuation Multiples

Dimerix's NTM/LTM revenue growth is 365%

Dimerix's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged $1.4M for the same period.

Over next 12 months, Dimerix's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Dimerix's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Dimerix and other 10K+ public comps

Dimerix Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth n/a XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 12% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee $1.4M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue n/a XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Dimerix Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Dimerix M&A and Investment Activity

Dimerix acquired  XXX companies to date.

Last acquisition by Dimerix was  XXXXXXXX, XXXXX XXXXX XXXXXX . Dimerix acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Dimerix

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Dimerix

When was Dimerix founded? Dimerix was founded in 1975.
Where is Dimerix headquartered? Dimerix is headquartered in Australia.
How many employees does Dimerix have? As of today, Dimerix has 12 employees.
Is Dimerix publicy listed? Yes, Dimerix is a public company listed on ASX.
What is the stock symbol of Dimerix? Dimerix trades under DXB ticker.
When did Dimerix go public? Dimerix went public in 1993.
Who are competitors of Dimerix? Similar companies to Dimerix include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Dimerix? Dimerix's current market cap is $163M
What is the current revenue of Dimerix? Dimerix's last 12-month revenue is $3.7M.
What is the current EBITDA of Dimerix? Dimerix's last 12-month EBITDA is -$12.0M.
What is the current EV/Revenue multiple of Dimerix? Current revenue multiple of Dimerix is 40.1x.
What is the current EV/EBITDA multiple of Dimerix? Current EBITDA multiple of Dimerix is -12.5x.
Is Dimerix profitable? Yes, Dimerix is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.